AHA 2023 Insights

 

 
 

 

AHA 2023 Insights: DAPA-MI - A Registry-Based Randomized Trial of Dapagliflozin in Patients With Acute Myocardial Infarction Without Diabetes or Heart Failure

189 views
November 21, 2023
Comments 0
Login to view comments. Click here to Login